By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 249
NEW YORK (Reuters Health) – Very low blood lead levels — well below the 10 mcg/dL threshold for deleterious effects set by the U.S. Centers for Disease Control…
NEW YORK (Reuters Health) – Results of a prospective, 14-year study indicate that women with psoriasis are at increased risk of incident diabetes and hypertension, verifying previous findings…
NEW YORK (Reuters Health) – The ability to detect major fetal anomalies by ultrasonography is reduced in pregnant women who are obese or diabetic, according to researchers at…
NEW YORK (Reuters Health) – A recent prospective study disproves earlier observations that non-steroidal anti-inflammatory drugs (NSAIDS) prevent Alzheimer dementia (AD). At best, NSAIDS may delay its onset,…
NEW YORK (Reuters Health) – High urinary levels of a carcinogen in tobacco may help predict risk of lung cancer in smokers, according to research reported at the…
NEW YORK (Reuters Health) – Overall, women who were treated for cancer during childhood are about 20% less likely to become pregnant than their unaffected sisters, according to…
NEW YORK (Reuters Health) – REM sleep behavior disorder is associated with a ìsubstantialî risk for eventual development of neurodegenerative diseases such as Parkinson disease and Lewy body…
NEW YORK (Reuters Health) – Vilazodone, the first of a new class of antidepressants known as indolalkylamines, has been shown in a phase III trial to be effective…
NEW YORK (Reuters Health) – Stereotactic body radiation therapy (SBRT) for early-stage non-small-cell lung cancer (NSCLC) results in “excellent 3-year local control and survival rates,” researchers report based…
NEW YORK (Reuters Health) – Elderly patients with Alzheimer’s disease treated with second-generation antipsychotics should be monitored closely for weight gain and dyslipidemia, according to an analysis of…
